CSIMarket

• Cash Flow Margin

Financial Strength

Mgmt. Effectiveness

Biotechnology & Drugs Industry Profitability

Profitability Information & Trends

Industry:

Biotechnology & Drugs ▼

Category:

Profitability▼

Period:

2020 ▼
- Current
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013

Biotechnology & Drugs ▼

Profitability▼

2020 ▼
- Current
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012

Biotechnology & Drugs Industry Profitability Ratios	4 Q 2020	3 Q 2020	2 Q 2020	1 Q 2020	4 Q 2019
	2020	2020	2020	2020	2019
Gross Margin	71.33 %	72.72 %	73.73 %	80.45 %	77.86 %
Gross Margin Annual (TTM)	72.19 %	75.57 %	76.86 %	79.22 %	78.98 %
Gross Margin Ranking	# 20	# 20	# 15	# 12	# 20
EBITDA Margin	16.17 %	30.31 %	5.5 %	24.86 %	47.73 %
EBITDA Margin Annual (TTM)	23.17 %	26.06 %	21.87 %	26.17 %	21.34 %
EBITDA Margin Ranking	# 47	# 19	# 71	# 16	# 8
Operating Margin	23.61 %	23.14 %	-	21.11 %	15.58 %
Operating Margin Annual (TTM)	20.68 %	17.9 %	13.79 %	16.23 %	9.06 %
Operating Margin Ranking	# 24	# 18	# 86	# 14	# 35
Pre-Tax Margin	3.37 %	15.92 %	-	15.37 %	14.51 %
Pre-Tax Margin Annual (TTM)	10.27 %	13.13 %	10.1 %	10.65 %	5.46 %
Pre-Tax Margin Ranking	# 71	# 25	# 86	# 15	# 24
Net Margin	7.54 %	12.83 %	-	19.46 %	15.35 %
Net Margin Annual (TTM)	8.85 %	10.32 %	7.98 %	10.48 %	4.18 %
Net Margin Ranking	# 46	# 27	# 94	# 4	# 24

New: More Biotechnology & Drugs Industry historic profitability ratios >>

Gross Margin Comment

Biotechnology & Drugs Industry's Revenue increased sequentially by 13.23 % faster than Gross Profit increase of 8.76 %, this led to contraction in Gross Margin to 71.33 %, below Industry average.

On the trailing twelve months basis gross margin in 4 Q 2020 fell to 72.19 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest gross margin. Gross margin total ranking has deteriorated compare to previous quarter from to 20.

Note, forth quarter Numbers include only companies who have reported forth quarter earnings results. Numbers change as more businesses report financial results. See the full List.

Gross Margin Statistics
High	Average	Low
102.36 %	79.71 %	71.39 %
4. quarter 2013		4. quarter 2020

Gross Margin Industry Ranking
Within:	No.
Healthcare Sector	# 1
Overall	# 20

Other Gross Margins
Compare Industry's gross margin to Nvda's or S&P	Gross profits within Biotechnology & Drugs Industry
Highest Ranking Gross Margins	Lowest Ranking Gross Margins
Profitability for Nvda's Suppliers	Definiton of Gross Margin

Biotechnology & Drugs Industry EBITDA Margin Statistics

EBITDA Margin Statistics
High	Average	Low
47.73 %	28.06 %	-6.51 %
4. quarter 2019		4. quarter 2018

EBITDA Margin Industry Ranking
Within:	No.
Healthcare Sector	# 4
Overall	# 47

EBITDA Margin Comment

Biotechnology & Drugs Industry's Ebitda Margin sequentially deteriorated to 16.17 % due to increase in operating costs and despite Revenue increase of 13.23 %.
Biotechnology & Drugs Industry's Ebitda Margin in 4 Q 2020 was lower than Industry average.

On the trailing twelve months basis Ebitda Margin in 4 Q 2020 fell to 23.17 %.

Within Healthcare sector 3 other industries have achieved higher ebitda margin. Ebitda margin total ranking has deteriorated compare to previous quarter from to 47.

Other EBITDA Margins
Compare Industry's EBITDA margin to Nvda's or S&P	Gross profits within Biotechnology & Drugs Industry
Highest Ranking EBITDA Margins	Lowest Ranking EBITDA Margins
Profitability for Industry's Suppliers	Industry Net Cash Flow Margin

Biotechnology & Drugs Industry Operating Margin Statistics

Operating Margin Comment

Biotechnology & Drugs Industry increased Operating Margin through reduction in operating costs and despite contraction in Operating Profit by -12.63 % and Revenue 13.23 %. Operating Margin in 4 Q 2020 was 23.61 %, below Industry average.

On the trailing twelve months basis operating margin in 4 Q 2020 grew to 20.68 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest operating margin. Operating margin total ranking has deteriorated compare to previous quarter from to 24.

Operating Margin Statistics
High	Average	Low
41.3 %	24.97 %	-10.83 %
4. quarter 2015		4. quarter 2018

Operating Margin Industry Ranking
Within:	No.
Healthcare Sector	# 1
Overall	# 24

Biotechnology & Drugs Industry Pre-Tax Margin Statistics

Pre-Tax Margin Statistics
High	Average	Low
38.85 %	20.36 %	-12.75 %
4. quarter 2015		4. quarter 2018

Pre-Tax Margin Comment

Biotechnology & Drugs Industry's Pre-Tax Margin sequentially deteriorated to 3.37 % due to increase in total costs and despite Revenue increase of 13.23 %.
Biotechnology & Drugs Industry's Pre-Tax Margin in 4 Q 2020 was lower than Industry average.

On the trailing twelve months basis Pre-Tax Margin in 4 Q 2020 fell to 10.27 %.

Within Healthcare sector 5 other industries have achieved higher Pre-Tax Margin. Pre-Tax Margin total ranking has deteriorated compare to previous quarter from to 71.

Pre-Tax Margin Industry Ranking
Within:	No.
Healthcare Sector	# 6
Overall	# 71

Pre-Tax Margins
Compare Industry's pre-tax margin to Nvda's or S&P	Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins	Lowest Ranking Net Margins
Profitability for Nvda's Competitors	Industry Tax Rate

Biotechnology & Drugs Industry Net Margin Statistics

Net Margin Comment

Biotechnology & Drugs Industry's Net Margin sequentially deteriorated to 7.54 % due to increase in total costs and despite Revenue increase of 13.23 %.
Biotechnology & Drugs Industry's Net Margin in 4 Q 2020 was lower than Industry average.

On the trailing twelve months basis Net margin in 4 Q 2020 fell to 8.85 %.

Within Healthcare sector 2 other industries have achieved higher Net margin. Net margin total ranking has deteriorated compare to previous quarter from to 46.

Net Margin Statistics
High	Average	Low
32.97 %	15.46 %	-18.25 %
4. quarter 2015		4. quarter 2017

Net Margin Industry Ranking
Within:	No.
Healthcare Sector	# 3
Overall	# 46

Other Net Margins
Compare Industry's net margin to Nvda's or S&P	Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins	Lowest Ranking Net Margins
Profitability for Nvda's Suppliers	Definiton of Net Margin

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar GOLF's Profile Stock Price GOLF's Financials Business Description Fundamentals Charts & Quotes GOLF's News Suppliers GOLF's Competitors Customers & Markets Economic Indicators GOLF's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071